Featured Products
Our Promise to You
Guaranteed product quality, expert customer support
ONLINE INQUIRY
TE671 Subline No.2
Cat.No.: CSC-6318W
Species: Human
Source: rhabdomyosarcoma
Morphology: continuous culture, grown as monolayer, morphology epithelial-like
Culture Properties: monolayer
- Specification
- Q & A
- Customer Review
Tumor: rhabdomyosarcoma;
Derived from: TE671 (described as medulloblastoma, then confirmed as rhabdomyosarcoma, probably identical to RD).
Common cell viability assays include MTT assay, Trypan blue exclusion assay, Alamar blue assay, propidium iodide staining, and ATP-based assays.
Ask a Question
Average Rating: 5.0 | 1 Scientist has reviewed this product
High quality
The high-quality retinoblastoma cells from Creative Bioarray have significantly accelerated our research into understanding the genetic and molecular factors contributing to this cancer.
16 Aug 2023
Ease of use
After sales services
Value for money
Write your own review
- You May Also Need
Description: Species: human, Caucasian male 51 years old;
Tumor: fibrosarcoma;
Derived from: metastasis to lung
Description: Established from a chemotherapy-resistant tumor sample obtained from the left knee of a 10-year-old boy with anaplastic osteoblastic sarcoma (Rosen grade IIB) in 1989
Description: Established from the recurrence of a dedifferentiated chondrosarcoma (grade III) of the muscle of the thigh from a 76-year-old man in 1989; tumorigenic chondrosarcomatous differentiation of xenografted tumor
Description: Established from an endometrial stromal sarcoma of the uterus of a 76-year-old Caucasian woman; cells were described as demonstrating a mainly mesenchymal phenotype with signs of epithelial characteristics within foci and an extensively multilayered growth pattern
Description: Established from the bone marrow metastasis of a 17-year-old man with undifferentiated (standard classification) or unclassified (Palmer classification) alveolar rhabdomyosarcoma; cells were described as carrying a p53 mutation, expressing high levels of both myogenin and myoD, and expressing the Pax3/FKHR fusion protein secondary to the t(2;13)(q35;q14) translocation
